ReviewAlzheimer's research & therapy2022

β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease.

Pablo Mohaupt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.